• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by MetLife Inc.

    3/11/25 5:20:04 PM ET
    $MET
    Life Insurance
    Finance
    Get the next $MET alert in real time by email
    FWP 1 d915943dfwp.htm FWP FWP

    Filed pursuant to Rule 433

    March 11, 2025

    Relating to

    Preliminary Prospectus Supplement dated March 11, 2025 to

    Prospectus dated November 17, 2022

    Registration Statement No. 333-268442

     

    LOGO

    MetLife, Inc.

    $1,000,000,000 6.350% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2055

    Final Term Sheet

    March 11, 2025

    The information in this final term sheet relates to the offering of the securities specified herein and should be read together with the preliminary prospectus supplement dated March 11, 2025 (the “Preliminary Prospectus Supplement”), including the documents incorporated by reference therein, and the accompanying prospectus dated November 17, 2022, filed pursuant to Rule 424(b) under the Securities Act of 1933 (Registration Statement File No. 333-268442). This final term sheet is qualified in its entirety by reference to the Preliminary Prospectus Supplement. Capitalized terms used but not defined herein shall have the respective meanings as set forth in the Preliminary Prospectus Supplement.

     

    Issuer:    MetLife, Inc. (“Issuer”)
    Securities:    6.350% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2055 (“Debentures”)
    Ranking:    Subordinated Unsecured (junior to all existing and future Senior Indebtedness; senior to all existing and future equity securities and the Junior Subordinated Obligations)
    Anticipated Ratings (Outlook)*:    Baa1 (Stable) / BBB (Stable) / BBB (Stable) (Moody’s / S&P / Fitch)
    Aggregate Principal Amount:    $1,000,000,000
    Price to the Public:    100% of principal amount, plus accrued interest, if any, from March 13, 2025
    Underwriting Discount:    1.000%
    Net Proceeds**:    $990,000,000
    Maturity Date:    March 15, 2055
    Trade Date:    March 11, 2025
    Settlement Date***:    March 13, 2025 (T+2)
    Interest Reset Date:    March 15, 2035 (“Initial Interest Reset Date”) and each date falling on the five-year anniversary of the preceding Interest Reset Date


    Interest Reset Period:    The period from, and including, the Initial Interest Reset Date to, but excluding, the next following Interest Reset Date and thereafter each period from, and including, each Interest Reset Date to, but excluding, the next following Interest Reset Date
    Interest Payment Dates:    Subject to the Option to Defer Interest Payments, semi-annually in arrears on March 15 and September 15 of each year, beginning on September 15, 2025, and the Maturity Date
    Interest Rate:    Subject to the Option to Defer Interest Payments, (i) 6.350%, accruing from, and including, March 13, 2025, to, but excluding, the Initial Interest Reset Date or any earlier redemption date; (ii) from, and including, the Initial Interest Reset Date, during each Interest Reset Period, at an annual rate equal to the Five-Year Treasury Rate as of the most recent Reset Interest Determination Date plus 2.078%
    Option to Defer Interest Payments:    So long as no Event of Default with respect to the Debentures has occurred and is continuing, the Issuer has the right to defer the payment of interest on the Debentures for one or more consecutive Interest Periods that do not exceed five years for any single Optional Deferral Period. The Issuer may not defer interest beyond the Maturity Date, any earlier accelerated Maturity Date arising from an Event of Default or any other earlier redemption of the Debentures. During an Optional Deferral Period, interest will continue to accrue on the Debentures at the then-applicable rate described above and deferred interest on the Debentures will bear additional interest at the then-applicable interest rate, compounded on each Interest Payment Date, subject to applicable law. If the Issuer has paid all deferred interest (including compounded interest thereon) on the Debentures, the Issuer can again defer interest payments on the Debentures as described above.
    Day Count Convention:    30/360
    Optional Redemption:    Redeemable in whole, at any time, or in part, from time to time, (i) on any Interest Payment Date on or after the Initial Interest Reset Date, at a redemption price equal to 100% of the principal amount of Debentures being redeemed, and (ii) prior to the Initial Interest Reset Date, at a redemption price equal to the greater of


      

    (1)   (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the Debentures matured on the Initial Interest Reset Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 35 basis points less (b) interest accrued to, but excluding, the redemption date, and

     

    (2)   100% of the principal amount of the Debentures to be redeemed;

     

    plus, in each case, accrued and unpaid interest thereon to, but excluding, the redemption date; provided that if the Debentures are not redeemed in whole, at least $25 million aggregate principal amount of the Debentures, excluding any Debentures held by MetLife, Inc. or any of its affiliates, must remain outstanding after giving effect to such redemption and all accrued and unpaid interest, including deferred interest (including compounded interest thereon), must be paid in full on all outstanding Debentures for all Interest Periods ending on or before the redemption date.

    Redemption after the Occurrence of a Tax Event, Rating Agency Event or Regulatory Capital Event:    Redeemable in whole, but not in part, at any time, within 90 days after the occurrence of a “Tax Event,” a “Rating Agency Event” or a “Regulatory Capital Event” at a redemption price equal to (i) in the case of a Tax Event or a Regulatory Capital Event, 100% of their principal amount plus accrued and unpaid interest to, but excluding, the redemption date or (ii) in the case of a Rating Agency Event, 102% of their principal amount plus accrued and unpaid interest to, but excluding, the redemption date.
    Consent to Terminate the Replacement Capital Covenants:    By purchasing the Debentures, holders of the Debentures, as holders of the “covered debt” under each of the Issuer’s Replacement Capital Covenants, are irrevocably consenting to the termination of each Replacement Capital Covenant and agree to waive any reliance on any covenant, promise or agreement (whether express or implied) set forth therein prior to such terminations, and will not take or attempt to take any action to enforce such covenant, promise or agreement set forth therein prior to those terminations.
    Denominations:    $2,000 and integral multiples of $1,000 in excess thereof
    CUSIP:    59156R CQ9
    ISIN:    US59156RCQ92


    Joint Book-Running Managers:    BNP Paribas Securities Corp.
    BofA Securities, Inc.
    Deutsche Bank Securities Inc.
    J.P. Morgan Securities LLC
    Morgan Stanley & Co. LLC
    TD Securities (USA) LLC
    Senior Co-Managers:    Barclays Capital Inc.
    Citigroup Global Markets Inc.
    Goldman Sachs & Co. LLC
    HSBC Securities (USA) Inc.
    Mizuho Securities USA LLC
    SMBC Nikko Securities America, Inc.
    Wells Fargo Securities, LLC
    Co-Managers:    BMO Capital Markets Corp.
    Santander US Capital Markets LLC
    Scotia Capital (USA) Inc.
    SG Americas Securities, LLC
    Truist Securities, Inc.
    U.S. Bancorp Investments, Inc.
    Junior Co-Managers:    R. Seelaus & Co., LLC
    Academy Securities, Inc.
    Blaylock Van, LLC

     

    *

    Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

    **

    Net Proceeds are net of Underwriting Discount and prior to expenses.

    ***

    It is expected that delivery of the Debentures will be made on or about March 13, 2025, which will be the second business day (T+2) following the date hereof. Under Rule 15c6-1 under the Securities Exchange Act of 1934, trades in the secondary market generally are required to settle in one business day (T+1), unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Debentures more than one business day prior to the scheduled settlement date will be required, by virtue of the fact that the Debentures will initially settle in T+2, to specify an alternative settlement arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the Debentures who wish to trade the Debentures more than one business day prior to the scheduled settlement date should consult their own advisors.

    The Issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in this offering will arrange to send you the prospectus if you request it by calling BNP Paribas Securities Corp. toll-free at 1-800-854-5674, BofA Securities, Inc. toll-free at 1-800-294-1322, Deutsche Bank Securities Inc. toll-free at 1-800-503-4611, J.P. Morgan Securities LLC collect at 1-212-834-4533, Morgan Stanley & Co. LLC toll-free at 1-866-718-1649 or TD Securities (USA) LLC toll-free at 1-855-495-9846.

    Get the next $MET alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MET

    DatePrice TargetRatingAnalyst
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    10/9/2024$97.00Buy
    TD Cowen
    9/5/2024$91.00Overweight
    Barclays
    1/8/2024$80.00Neutral → Buy
    Goldman
    11/17/2023$71.00Overweight
    Barclays
    10/5/2023$71.00Hold
    Deutsche Bank
    9/14/2023$58.00 → $72.00Hold → Buy
    Jefferies
    1/9/2023$80.00 → $78.00Buy → Neutral
    Goldman
    More analyst ratings

    $MET
    Financials

    Live finance-specific insights

    See more
    • MetLife Declares Second Quarter 2025 Preferred Stock Dividends

      MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35141735 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE:MET). Quarterly dividend of $296.875 per share on the company's 4.75% non-cumul

      5/15/25 4:15:00 PM ET
      $MET
      Life Insurance
      Finance
    • MetLife Announces 1Q 2025 Results

      MetLife, Inc. (NYSE:MET) today announced its first quarter 2025 results. Earnings Per Share   Return on Equity (ROE) 1Q 2025   1Q 2025 Net Income $ 1.28   ROE 14.9 % Adjusted Earnings $ 1.96   Adjusted ROE 14.4 % Net income increased 10% to $879 million. Premiums, fees and other revenues (PFOs) increased 14% to $13.6 billion. Adjusted earnings rose 1% to $1.3 billion. Higher life underwriting margins, volume growth and variable investment income were partially offset by unfavorable foreign currency impacts and lower recurring interest margins. Book value increased 2% to $35.16 per share. A

      4/30/25 4:15:00 PM ET
      $MET
      Life Insurance
      Finance
    • MetLife CFO John McCallion Provides First Quarter 2025 Financial Update Video

      MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and CFO, and head of MetLife Investment Management, has provided a first quarter 2025 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430216095/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers b

      4/30/25 4:15:00 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    Leadership Updates

    Live Leadership Updates

    See more
    • MetLife Investment Management Agrees to Acquire Traditional Fixed Income and Equity Portfolio Management Teams Managing $6 Billion From Mesirow

      Acquisition includes high yield, strategic fixed income and small-cap equity teams MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has reached a definitive agreement to acquire three investment teams and assets managed by Mesirow, an independent, employee-owned financial services firm. MIM is acquiring the high yield and bank loan, strategic fixed income and small-cap equity teams and certain related investment products. Under the terms of the transaction, about $6 billion of assets managed by the acquired teams will transfer to MIM, subject to customary approvals and consents. The acquisition is consi

      1/8/25 8:30:00 AM ET
      $MET
      Life Insurance
      Finance
    • MetLife Investment Management Names Kerry O'Brien Global Head of Insurance Asset Management and Liability Solutions

      MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has appointed Kerry O'Brien as global head of Insurance Asset Management and Liability Solutions. She will be responsible for the execution of investment strategies for the MetLife general account, helping drive growth in MIM's third-party insurance client channel as well as working with teams to drive liability solutions across other client segments. O'Brien will lead a team with an insurance investing heritage of nearly 150 years and an active role in managing MetLife's $414.1 billion general account as well as assets for third-party insurance clients. Sh

      12/2/24 8:30:00 AM ET
      $MET
      Life Insurance
      Finance
    • MetLife Worldwide Benefits and GeoBlue® to Offer Joint Solution

      Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such

      6/25/24 9:00:00 AM ET
      $MET
      Life Insurance
      Finance

    $MET
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Johnson Jeh C. bought $879 worth of shares (17 units at $51.69) and was granted 19 shares, increasing direct ownership by 1% to 2,545 units (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      12/18/23 5:20:05 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by MetLife Inc.

      SC 13D/A - METLIFE INC (0001099219) (Subject)

      11/1/24 5:05:26 PM ET
      $MET
      Life Insurance
      Finance
    • Amendment: SEC Form SC 13D/A filed by MetLife Inc.

      SC 13D/A - METLIFE INC (0001099219) (Subject)

      8/1/24 4:38:49 PM ET
      $MET
      Life Insurance
      Finance
    • SEC Form SC 13D/A filed by MetLife Inc. (Amendment)

      SC 13D/A - METLIFE INC (0001099219) (Subject)

      5/2/24 5:34:57 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mckenzie Diana was granted 153 shares, increasing direct ownership by 0.72% to 21,503 units (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      6/12/25 4:21:12 PM ET
      $MET
      Life Insurance
      Finance
    • Director Hubbard Robert Glenn was granted 650 shares, increasing direct ownership by 0.66% to 99,525 units (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      6/12/25 4:20:59 PM ET
      $MET
      Life Insurance
      Finance
    • Director Hay Laura J was granted 22 units of Common Stock, increasing direct ownership by 0.71% to 3,139 units (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      6/12/25 4:20:48 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    SEC Filings

    See more
    • SEC Form 144 filed by MetLife Inc.

      144 - METLIFE INC (0001099219) (Subject)

      6/13/25 4:11:58 PM ET
      $MET
      Life Insurance
      Finance
    • SEC Form S-3ASR filed by MetLife Inc.

      S-3ASR - METLIFE INC (0001099219) (Filer)

      5/16/25 5:01:44 PM ET
      $MET
      Life Insurance
      Finance
    • MetLife Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - METLIFE INC (0001099219) (Filer)

      5/15/25 4:20:25 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • New PPO Dental Plans More Competitive Against HMOs

      LOS ANGELES, June 11, 2025 /PRNewswire/ -- DentalInsurance.com, the leader in dental insurance comparison shopping, has broadened its inventory of PPO dental plans offering high maximum benefits. A maximum benefit is the annual cap on insurance company spending toward a consumer's covered dental care. PPO plans have a maximum benefit limit while HMO dental insurance doesn't. PPOs, however, have much wider dentist networks than most competing HMO plans. This helps consumers receive quality dental care from a trusted preferred dentist. By adding high maximum benefits, a new generation of PPO dental plans have become an even more attractive option for consumers.

      6/11/25 10:07:00 AM ET
      $CI
      $HUM
      $MET
      Medical Specialities
      Health Care
      Life Insurance
      Finance
    • AM Best Assigns Indicative Issue Credit Ratings to MetLife, Inc.'s New Shelf Registration

      AM Best has assigned indicative Long-Term Issue Credit Ratings of "a-" (Excellent) to senior unsecured issues, "bbb+" (Good) to subordinated issues, and "bbb" (Good) to preferred stock to the recently filed shelf registration of MetLife, Inc. (MetLife) (headquartered in New, NY) (NYSE:MET). The outlook assigned to these Credit Ratings (ratings) is stable. Concurrently, AM Best has withdrawn the ratings on the previous shelf registrations, which expired. MetLife's proforma financial leverage and the historical interest coverage ratios are in line with its current ratings, and its holding company liquidity is strong. This press release relates to Credit Ratings that have been published on A

      5/21/25 10:10:00 AM ET
      $MET
      Life Insurance
      Finance
    • MetLife Names Jane Slusark as Chief Communications Officer

      MetLife, Inc. (NYSE:MET) today announced that Jane Slusark will join the company as chief communications officer, effective June 9, 2025. In this role, she will oversee the company's global communications strategy, including internal and external communications and media relations. "Jane brings strategic vision, operational rigor and deep expertise to this role," said Michael Roberts, chief marketing officer at MetLife. "She has a proven track record of building trust and deepening engagement, which will be instrumental as we continue to enhance our reputation with customers, employees, and communities around the world." Slusark comes to MetLife from Principal Financial Group, where she w

      5/19/25 1:01:00 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BMO Capital Markets initiated coverage on MetLife with a new price target

      BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00

      1/23/25 7:50:09 AM ET
      $MET
      Life Insurance
      Finance
    • TD Cowen initiated coverage on MetLife with a new price target

      TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00

      10/9/24 7:52:22 AM ET
      $MET
      Life Insurance
      Finance
    • Barclays initiated coverage on MetLife with a new price target

      Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00

      9/5/24 8:14:53 AM ET
      $MET
      Life Insurance
      Finance